20/20 Biolabs, Inc. (AIDX) income statement
AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.18−0.00 (-2.64%)
Close on Nov 19, 2026Market cap $2.31MP/E –Yield –
20/20 Biolabs, Inc. financial ratios
See a number that looks wrong?